Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer (Q33349892)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12966417

retrieved

26 July 2017

title

Phase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12966417

retrieved

26 July 2017

main subject

irinotecan

1 reference

based on heuristic

inferred from title

ifosfamide

1 reference

based on heuristic

inferred from title

cisplatin

1 reference

based on heuristic

inferred from title

author name string

A Fujita

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12966417

retrieved

26 July 2017

T Ohkubo

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12966417

retrieved

26 July 2017

H Hoshino

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12966417

retrieved

26 July 2017

H Takabatake

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12966417

retrieved

26 July 2017

S Tagaki

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12966417

retrieved

26 July 2017

K Sekine

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12966417

retrieved

26 July 2017

S Abe

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12966417

retrieved

26 July 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12966417

retrieved

26 July 2017

published in

British Journal of Cancer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12966417

retrieved

26 July 2017

volume

89

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12966417

retrieved

26 July 2017

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12966417

retrieved

26 July 2017

page(s)

1008-1012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12966417

retrieved

26 July 2017

cites work

Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376953

retrieved

28 July 2018

Combination chemotherapy in patients with malignant pleural effusions from non-small cell lung cancer : cisplatin, ifosfamide, and irinotecan with recombinant human granulocyte colony-stimulating factor support

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376953

retrieved

28 July 2018

Phase I study of cisplatin, ifosfamide and irinotecan with rhG-CSF support in advanced non-small cell lung cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376953

retrieved

28 July 2018

A phase II trial of combination of CPT-11 and cisplatin for advanced non-small-cell lung cancer. CPT-11 Lung Cancer Study Group

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376953

retrieved

28 July 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376953

retrieved

28 July 2018

Phase I study of carboplatin, irinotecan and docetaxel on a divided schedule with recombinant human granulocyte colony stimulating factor support in patients with stage IIIB or IV non-small cell lung cancer

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601230

retrieved

21 January 2018

Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12966417

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of carboplatin, docetaxel and irinotecan with recombinant human granulocyte colony stimulating factor support in patients with advanced non-small cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12966417

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12966417

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12966417

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12966417

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12966417

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irinotecan (CPT-11) in combination with weekly administration of cisplatin (CDDP) for non-small-cell lung cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12966417

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/12966417

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/SJ.BJC.6601230

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12966417

retrieved

26 July 2017

Dimensions Publication ID

1032142227

0 references

PMC publication ID

2376953

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12966417

retrieved

26 July 2017

PubMed publication ID

12966417

1 reference

stated in

Europe PubMed Central

PubMed publication ID

12966417

retrieved

26 July 2017

ResearchGate publication ID

10574708

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33349892&oldid=2195271062"